SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021928
Filing Date
2022-11-03
Accepted
2022-11-03 16:31:31
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-20220930.htm   iXBRL 10-Q 2099069
2 EX-10.1 onct-ex10_1.htm EX-10.1 34612
3 EX-31.1 onct-ex31_1.htm EX-31.1 19871
4 EX-31.2 onct-ex31_2.htm EX-31.2 19854
5 EX-32.1 onct-ex32_1.htm EX-32.1 9601
6 EX-32.2 onct-ex32_2.htm EX-32.2 10041
  Complete submission text file 0000950170-22-021928.txt   6847193

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20220930.xsd EX-101.SCH 46278
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20220930_def.xml EX-101.DEF 142105
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT onct-20220930_cal.xml EX-101.CAL 28153
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20220930_lab.xml EX-101.LAB 367699
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20220930_pre.xml EX-101.PRE 248278
46 EXTRACTED XBRL INSTANCE DOCUMENT onct-20220930_htm.xml XML 1205444
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 221358561
SIC: 2834 Pharmaceutical Preparations